13F Holdings
中文EN

EYE National Vision Holdings, Inc.

Ophthalmic Goods · Nasdaq · SEC CIK 1710155 · Fiscal year ends 01/02

Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.0%
TTM net income YoY2,964.0%
TTM EPS YoY2,833.3%
Revenue 3-yr CAGR4.5%
Net income 3-yr CAGR—

Margins

Gross margin58.8%
Operating margin5.1%
Net margin3.2%
FCF margin3.3%
EBITDA margin9.6%

Returns

ROE7.5%
ROA3.3%
ROIC (approx.)7.2%
Asset turnover1.04x

Leverage & solvency

Liabilities / assets55.0%
Debt / equity0.25x
Current ratio0.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.24x
Accruals ratio-4.1%
Payout ratio—
Capex / revenue3.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252026-01-03FY20242024-12-28FY20232023-12-30FY20222022-12-31FY20212022-01-01
Income statement
Revenue$1.99B$1.82B$1.76B$1.64B$2.08B
Cost of revenue$819.47M$764.06M$734.65M$667.66M$904.78M
Gross profit$1.17B$1.06B$1.02B$977.01M$1.17B
SG&A expense$1.02B$938.52M$904.76M$832.61M$900.80M
Operating income$58.83M-$10.36M$24.49M$52.77M$174.94M
Interest expense————$25.61M
Pretax income$41.68M-$25.68M$9.55M$52.30M$149.32M
Income tax$12.08M$1.48M$6.01M$15.54M$21.08M
Net income$29.60M-$28.50M-$65.90M$42.12M$128.24M
EBITDA$149.98M$80.99M$114.36M$141.46M$272.03M
EPS (basic)0.37-0.36-0.840.531.57
EPS (diluted)0.37-0.36-0.840.521.43
Weighted avg. shares (diluted)80.58M78.59M78.60M80.30M96.13M
Balance sheet
Cash & equivalents$38.71M$75.24M$149.90M$230.62M$306.88M
Receivables$57.32M$49.94M$86.85M$79.89M$55.70M
Inventory$89.32M$93.92M$119.91M$123.16M$123.67M
Current assets$225.72M$249.83M$396.67M$473.84M$514.58M
PP&E, net$344.62M$362.18M$360.19M$359.77M$346.44M
Goodwill$700.64M$698.30M$717.54M$777.61M$777.61M
Intangibles$7.55M$8.27M$20.17M$34.67M$42.02M
Total assets$1.98B$2.01B$2.17B$2.29B$2.29B
Current liabilities$412.41M$468.27M$397.70M$344.26M$343.80M
Short-term debt$13.25M$98.02M$7.50M$0$0
Long-term debt$223.24M$239.15M$437.68M$546.23M$543.57M
Total debt$236.49M$337.17M$445.18M$546.23M$543.57M
Total liabilities$1.11B$1.19B$1.34B$1.39B$1.37B
Shareholders' equity$869.53M$816.33M$829.42M$901.11M$925.98M
Net debt$197.78M$261.93M$295.29M$315.61M$236.69M
Shares outstanding79.42M78.78M78.31M78.99M81.41M
Cash flow statement
Operating cash flow$146.29M$133.65M$173.03M$119.20M$258.94M
Capital expenditure$72.84M$95.50M$114.77M$113.55M$95.52M
Free cash flow$73.45M$38.14M$58.26M$5.65M$163.42M
Investing cash flow-$76.61M-$96.09M-$115.82M-$110.89M-$92.90M
Financing cash flow-$104.62M-$113.34M-$136.81M-$84.56M-$234.32M
Depreciation & amortization$91.15M$91.35M$89.87M$88.69M$97.09M
Stock-based compensation$23.69M$16.71M$20.17M$13.51M$14.89M
Share buybacks$3.21M$3.09M$28.41M$84.39M$73.30M

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.